News 2009
Jun 2, 2010
Merus Announces Publication of the Generation of Single, Clonal Cell lines
Press release
[More]
Older news
Oct 5, 2007
Issuance of a cornerstone patent covering the expression of antibody mixtures
Utrecht, The Netherlands, October 5, 2007 - Merus B.V. announced the issuance of an important patent by the United States Patent and Trademark Office.
Jan 17, 2006
Merus BV Closes Series A Financing
Utrecht, The Netherlands, January 17, 2006 - Merus B.V., a privately held biomedical company, today announced the completion of a financial package with Aglaia Oncology Seed Fund B.V.
Jun 10, 2004
Driebergen, The Netherlands - Dutch biotechnology company Crucell N.V.
Feb 10, 2004
Merus b.v. Licenses Oligoclonics™ Production Technology for Therapeutic Antibody Mixtures
Driebergen, The Netherlands - Merus b.v. today announced that it has concluded an agreement with Crucell Holland B.V. to license from...